I’ve got my eye on four trends – the maturation of AI-powered drug development, fierce competition in the GLP-1 space, the ...

A consistent stream of supply issues has disrupted deliveries of vital medicines – from hormone replacement therapy and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

India's J B Chemicals & Pharmaceuticals reported a bigger third-quarter profit on Tuesday, helped by sustained domestic demand for its drugs for chronic and acute conditions.

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

The shift in the DEI industry, consultants and analysts say, has left many professionals concerned about their job stability ...

Tariffs declared by the US that had been set to start for two nations overnight would push costs up for many healthcare items.

If implemented, this initiative could be a game-changer. Industry insiders estimate that Bangladesh could save $1 billion in foreign currency annually by reducing its reliance on imported APIs ...

Kennedy offers hope that we can, in fact, “make America healthy again” by reforming a gargantuan bureaucracy that touches ...

China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The ...

APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...